Understanding differences in predictions of HPV vaccine effectiveness: A comparative model-based analysis

This publication has 52 references indexed in Scilit:

• Cost-Effectiveness Analysis of Human Papillomavirus Vaccination in the Netherlands
  JNCI Journal of the National Cancer Institute, 2009
• Cost-Effectiveness of Cervical Cancer Screening With Human Papillomavirus DNA Testing and HPV-16,18 Vaccination
  JNCI Journal of the National Cancer Institute, 2008
• Cost-effectiveness analysis of the introduction of a quadrivalent human papillomavirus vaccine in France
  International Journal of Technology Assessment in Health Care, 2008
• The potential cost-effectiveness of prophylactic human papillomavirus vaccines in Canada
  Vaccine, 2007
• Assessing the introduction of universal human papillomavirus vaccination for preadolescent girls in The Netherlands
  Vaccine, 2007
• Strategies for the introduction of human papillomavirus vaccination: modelling the optimum age- and sex-specific pattern of vaccination in Finland
  British Journal of Cancer, 2007
• Model for Assessing Human Papillomavirus Vaccination Strategies
  Emerging Infectious Diseases, 2007
• Epidemiology of HPV 16 and Cervical Cancer in Finland and the Potential Impact of Vaccination: Mathematical Modelling Analyses
  PLoS Medicine, 2006
• Projected Clinical Benefits and Cost-effectiveness of a Human Papillomavirus 16/18 Vaccine
  JNCI Journal of the National Cancer Institute, 2004
• Benefits and Costs of Using HPV Testing to Screen for Cervical Cancer
  JAMA, 2002